Join
Live feed
·
INSIDERFilingvia Quantisnow
Clearside Biomedical Inc. logo

SEC Form 4: Deignan Charles A. was granted 43,750 shares and sold $18,461 worth of shares (8,833 units at $2.09) as part of a pre-agreed trading plan, increasing direct ownership by 11% to 351,366 units to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
CLSD· Clearside Biomedical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLSD (Clearside Biomedical Inc.) and more on Quantisnow.